山东大学耳鼻喉眼学报 ›› 2019, Vol. 33 ›› Issue (1): 9-12.doi: 10.6040/j.issn.1673-3770.1.2018.019

• 专家笔谈 • 上一篇    下一篇

Ⅱ型固有淋巴细胞在变应性鼻炎发病机制中的作用

郭胤仕*(),卢慧   

  1. 上海交通大学医学院附属仁济医院过敏科,上海 200127
  • 收稿日期:2017-10-08 出版日期:2019-01-20 发布日期:2019-01-28
  • 通讯作者: 郭胤仕 E-mail:drguoyinshi@163.com
  • 作者简介:郭胤仕,医学博士。现任上海交通大学医学院附属仁济医院过敏科(变态反应科)主任、过敏疾病防治中心主任、变态反应及呼吸内科主任医师、教授,上海-渥太华联合医学院特聘教授。主要学术任职:中华医学会变态反应学分会副主任委员,中国医疗保健国际交流促进会过敏科学分会副主任委员,中国医师协会变态反应医师分会常委,中华预防医学会过敏病预防与控制委员会常委,上海市医学会变态反应专科分会主任委员。《中华临床免疫和变态反应杂志》《Allergy中文版》《现代免疫学》《上海交通大学学报(医学版)》《中华医学百科全书.变态反应卷》等编委或特约审稿人;国家科技部、教育部、卫健委、人社部、食药局项目评审专家;世界变态反应组织(WAO)、欧洲变态反应与临床免疫学会(EAACI)、美国变态反应-哮喘-免疫学院(ACAAI)、欧洲呼吸学会(ERS)、亚太呼吸学会(APRS)会员。以第一作者或通讯作者在《Blood》《Journal of Experimental Medicine》《Asian Pacific Journal of Allergy Immunology》《International Journal of Clinical and Experimental Pathology》《Chinese Medical Journal》《中华内科杂志》《中华结核和呼吸杂志》《中华临床免疫和变态反应杂志》《中华检验医学杂志》《中国免疫学杂志》等刊物发表学术论文60余篇,其中SCI论文近20篇。主持或参与完成10余项国家及省部级科研项目,曾获省部级科学技术进步奖二等奖、三等奖及省部级教学成果二等奖。主编或参编《临床变态反应学》《支气管哮喘》《慢性阻塞性肺疾病》《如何防治过敏》等多部教材或专著
  • 基金资助:
    2013国家临床重点专科建设项目;国家卫生计生委公益性行业科研专项(2015SQ00136)

Research progress of group Ⅱ innate lymphoid cells in the allergic rhinitis

Yinshi GUO*(),Hui LU   

  1. Department of Allergy & Immunology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
  • Received:2017-10-08 Online:2019-01-20 Published:2019-01-28
  • Contact: Yinshi GUO E-mail:drguoyinshi@163.com
  • Supported by:
    2013国家临床重点专科建设项目;国家卫生计生委公益性行业科研专项(2015SQ00136)

摘要:

变应性鼻炎是常见的呼吸道过敏性炎症疾病。Th2细胞的激活被认为是其中最重要的机制,天然免疫和适应性免疫均参与其中。天然免疫细胞是一类重要的机体内稳态调节因子,Ⅱ型固有淋巴细胞(ILC2s)是天然免疫细胞中Th2细胞的“镜相细胞”,分泌多种Th2因子,参与多种过敏性炎症病理过程。本文将就ILC2s在变应性鼻炎中作用的研究进展做一综述。

关键词: 变应性鼻炎, Th2细胞, Ⅱ型固有淋巴细胞

Abstract:

Allergic rhinitis (AR) is an allergic respiratory inflammation. T helper type 2 (Th2) cell activation plays an important role in the mediation of the disease. AR involves the innate and adaptive immune systems. Type 2 innate lymphoid cells (ILC2s) are considered the innate counterparts of Th2 cells based on the cytokines they express. Accumulating evidence has demonstrated that innate immune cells function as homeostatic regulators in the body. ILC2s contribute to the pathology of allergic inflammatory diseases. Here, we review the characteristics of ILC2s and progress of research on the mechanism of AR.

Key words: Allergic rhinitis, Type 2 T helper cells, Group Ⅱ innate lymphoid cells

中图分类号: 

  • R562
1 Brożek JL , Bousquet J , Agache I , et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision[J]. J Allergy Clin Immunol, 2017, 140 (4): 950- 958.
doi: 10.1016/j.jaci.2017.03.050
2 Bernstein DI , Schwartz G , Bernstein JA . Allergic rhinitis: mechanisms and treatment[J]. Immunol Allergy Clin North Am, 2016, 36 (2): 261- 278.
doi: 10.1016/j.iac.2015.12.004
3 Eifan AO , Durham SR . Pathogenesis of rhinitis[J]. Clin Exp Allergy, 2016, 46 (9): 1139- 1151.
doi: 10.1111/cea.12780
4 Thiriou D , Morianos I , Xanthou G , et al. Innate immunity as the orchestrator of allergic airway inflammation and resolution in asthma[J]. Int Immunopharmacol, 2017, 48: 43- 54.
doi: 10.1016/j.intimp.2017.04.027
5 王静, 杨琨. 固有淋巴细胞研究进展[J]. 细胞与分子免疫学杂志, 2015, 31 (11): 1554- 1559.
doi: 10.13423/j.cnki.cjcmi.007566
6 Artis D , Spits H . The biology of innate lymphoid cells[J]. Nature, 2015, 517 (7534): 293- 301.
doi: 10.1038/nature14189
7 Kotas ME , Locksley RM . Why innate lymphoid cells?[J]. Immunity, 2018, 48 (6): 1081- 1090.
doi: 10.1016/j.immuni.2018.06.002
8 Yanagibashi T , Satoh M , Nagai Y , et al. Allergic diseases: From bench to clinic - Contribution of the discovery of interleukin-5[J]. Cytokine, 2017, 98: 59- 70.
doi: 10.1016/j.cyto.2016.11.011
9 Lloyd CM, Snelgrove RJ. Type 2 immunity: Expanding our view[J]. Sci Immunol, 2018, 3(25). pii: eaat1604. doi:10.1126/sciimmunol.aat1604.
10 马若愚, 郭婧, 汪洌. 固有淋巴细胞的发育与功能[J]. 生命科学, 2015, 27 (4): 417- 424.
doi: 10.13376/j.cbls/2015054
MA Ruoyu , GUO Jing , WANG Lie . The development and function of innate lymphoid cells[J]. Chinese Bulletin of Life Sciences, 2015, 27 (4): 417- 424.
doi: 10.13376/j.cbls/2015054
11 Bernink JH , Germar K , Spits H . The role of ILC2 in pathology of type 2 inflammatory diseases[J]. Curr Opin Immunol, 2014, 31: 115- 120.
doi: 10.1016/j.coi.2014.10.007
12 Dahlgren MW , Molofsky AB . All along the watchtower: group 2 innate lymphoid cells in allergic responses[J]. Curr Opin Immunol, 2018, 54: 13- 19.
doi: 10.1016/j.coi.2018.05.008
13 Martinez-Gonzalez I , Ghaedi M , Steer CA , et al. ILC2 memory: Recollection of previous activation[J]. Immunol Rev, 2018, 283 (1): 41- 53.
doi: 10.1111/imr.12643
14 Aron JL , Akbari O . Regulatory T cells and type 2 innate lymphoid cell-dependent asthma[J]. Allergy, 2017, 72 (8): 1148- 1155.
doi: 10.1111/all.13139
15 Shamji MH , Durham SR . Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers[J]. J Allergy Clin Immunol, 2017, 140 (6): 1485- 1498.
doi: 10.1016/j.jaci.2017.10.010
16 Dhariwal J , Edwards MR , Johnston SL , et al. Anti-viral agents: potential utility in exacerbations of asthma[J]. Curr Opin Pharmacol, 2013, 13 (3): 331- 336.
doi: 10.1016/j.coph.2013.04.010
17 Zhong H , Fan XL , Yu QN , et al. Increased innate type 2 immune response in house dust mite-allergic patients with allergic rhinitis[J]. Clin Immunol, 2017, 183: 293- 299.
doi: 10.1016/j.clim.2017.09.008
18 Bartemes KR , Kephart GM , Fox SJ , et al. Enhanced innate type 2 immune response in peripheral blood from patients with asthma[J]. J Allergy Clin Immunol, 2014, 134 (3): 671- 678.e4.
doi: 10.1016/j.jaci.2014.06.024
19 Matsushita K , Kato Y , Akasaki S , et al. Proallergic cytokines and group 2 innate lymphoid cells in allergic nasal diseases[J]. Allergol Int, 2015, 64 (3): 235- 240.
doi: 10.1016/j.alit.2014.12.008
20 Lin L , Dai F , Wei JJ , et al. Allergic inflammation is exacerbated by allergen-induced type 2 innate lymphoid cells in a murine model of allergic rhinitis[J]. Rhinology, 2017, 55 (4): 339- 347.
doi: 10.4193/Rhin17.065
21 Dhariwal J , Cameron A , Trujillo-Torralbo MB , et al. Mucosal type 2 innate lymphoid cells are a key component of the allergic response to aeroallergens[J]. Am J Respir Crit Care Med, 2017, 195 (12): 1586- 1596.
doi: 10.1164/rccm.201609-1846OC
22 Lao-Araya M , Steveling E , Scadding GW , et al. Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy[J]. J Allergy Clin Immunol, 2014, 134 (5): 1193- 1195.e4.
doi: 10.1016/j.jaci.2014.07.029
23 Fan DC , Wang XD , Wang CS , et al. Suppression of immunotherapy on group 2 innate lymphoid cells in allergic rhinitis[J]. Chin Med J, 2016, 129 (23): 2824- 2828.
doi: 10.4103/0366-6999.194642
[1] 吕倩,唐源,顾子君,施赛磊,刘萍,万文锦. 变应性鼻炎患者疾病获益感现状及影响因素分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 21-28.
[2] 顾敏,陆美萍. 纳米药物输送系统在变应性鼻炎过敏原免疫治疗中的应用进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 106-111.
[3] 秦娜娜,李玉芬,孙雨浩,魏健,李钦. 基于TGF-β1/Smad信号通路探讨白细胞介素13受体α2对变应性鼻炎大鼠鼻黏膜组织重塑的影响[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 71-77.
[4] 熊琴, 张砚, 乌日娜, 李锋, 唐力行. 鼻用糖皮质激素在儿童中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 160-167.
[5] 许雪萌,樊磊,喻望博,蒋芝月,潘晨,黄泳芹. 奥马珠单抗联合特异性免疫治疗变应性鼻炎疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 26-33.
[6] 刘怡君,谷悦,官大宇,杨玉成,沈暘. 翼管神经切断术在难治性变应性鼻炎中远期临床疗效和安全性[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 42-48.
[7] 张婷,王美兰,高映勤. 白细胞介素35在变应性鼻炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 139-147.
[8] 张竹萍,彭孜灿,肖振龙,李程,喻迪,王兴龙,陈伟,郭蓓. 新型鼻分泌物嗜酸粒细胞阳离子蛋白-髓过氧化物酶试纸在变应性鼻炎中的应用价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 129-134.
[9] 刘畅,杨景朴,高雨,王文佳. 长春地区儿童变应性鼻炎变应原检测结果分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 51-58.
[10] 周荷青,申琪. 中医药治疗变应性鼻炎疗效的生物标志物研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 168-176.
[11] 王曼娴,郑泉,杨亮. 细菌裂解物治疗变应性鼻炎的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 141-145.
[12] 刘畅,方宏艳,刘敩,富东娜,王贺,王晶,杨景朴. 长春地区秋季变应性鼻炎蒿属花粉致敏特征分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 13-19.
[13] 朱朗,刘志奇. 移动医疗提供的真实世界数据在变应性鼻炎治疗方案中的参考[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 135-139.
[14] 张静祎,董湘依,牟亚魁,宋西成. 细胞焦亡在耳鼻咽喉科疾病中的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 140-148.
[15] 张丽净,冯晓星,刘南仙,赵辉明,陈月华. 石墨烯养护鼻罩结合尘螨的皮下特异性免疫治疗在尘螨变应性鼻炎患者中的应用分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 26-32.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!